• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2021 January

Post Archive by Month

JAK inhibitors for atopic dermatitis: a promising treatment modality.

In Dermatology
by ClinOwl
January 23, 2021

Atopic dermatitis (AD) is chronic, pruritic, inflammatory skin disease that affects a significant portion of the population in industrialized nations. For non-responders to conventional therapies, AD can significantly reduce sleep …

The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa; results of a prospective European cohort study.

In Dermatology
by ClinOwl
January 23, 2021

Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current Hidradenitis Suppurativa (HS) guidelines. However, evidence for their efficacy is drawn from small studies, often without …

View Post

Renal Insufficiency May Worsen Multiple Myeloma Outcomes

In HealthDay News
by Healthday
January 22, 2021

Risk for disease progression or death increased for those with renal insufficiency in relapsed/refractory, newly diagnosed MM

View Post

Nearly Two-Thirds of Canadian Cardiac Physicians Burned Out

In HealthDay News
by Healthday
January 22, 2021

Burnout driven by perception of inadequate staffing levels, being treated unfairly at work

View Post

Opioid Use May Contribute to Risk for Pancreatic Cancer

In HealthDay News
by Healthday
January 22, 2021

At the state level, opioid death rate at four years prior predicted the initial incidence of pancreatic cancer

View Post

Methamphetamine OD Deaths Up for All Races, Ethnicities

In HealthDay News
by Healthday
January 22, 2021

Highest rates within each sex seen for non-Hispanic American Indian or Alaska Native individuals, followed by non-Hispanic Whites

View Post

Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19

In HealthDay News
by Healthday
January 22, 2021

Preliminary results of the study conducted by drug maker Eli Lilly have not been peer-reviewed or published

View Post

FDA Approves First Monthly Injectable Regimen for HIV

In HealthDay News
by Healthday
January 22, 2021

Trials show virologic suppression in comparable numbers of patients receiving monthly injection with Cabenuva, daily current antiretroviral regimen

Bromhidrosis Treatment Modalities: A Literature Review.

In Dermatology
by ClinOwl
January 22, 2021

Treatment options for Bromhidrosis include Botulinum toxin therapy, microwave-based therapy, laser therapy, and surgerical intervention. There have been limited studies comparing their efficacies.The purpose of this literature review is to …

Small molecule inhibitors and biologics in treating nail psoriasis: a systematic review and network meta-analysis.

In Dermatology
by ClinOwl
January 22, 2021

Various systemic immunomodulating therapies have been investigated to treat nail psoriasis, but the efficacy remains unclear.To perform a systematic review and network meta-analysis (NMA) to evaluate the efficacy of small …

  • Page 5 of 30
  • ←
  • 1
  • ...
  • 4
  • 5
  • 6
  • ...
  • 30
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

January 2021
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Dec   Feb »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer